Compare Wai Chun Bio-Technology Ltd. with Similar Stocks
Dashboard
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -7.50% over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.14 times
2
Flat results in Jun 25
3
Risky -
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
35.64%
0%
35.64%
6 Months
50.0%
0%
50.0%
1 Year
142.86%
0%
142.86%
2 Years
91.73%
0%
91.73%
3 Years
99.22%
0%
99.22%
4 Years
493.02%
0%
493.02%
5 Years
222.78%
0%
222.78%
Wai Chun Bio-Technology Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-7.50%
EBIT Growth (5y)
-26.84%
EBIT to Interest (avg)
0.73
Debt to EBITDA (avg)
12.83
Net Debt to Equity (avg)
-1.56
Sales to Capital Employed (avg)
15.00
Tax Ratio
13.63%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.57%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.34
EV to EBIT
-17.81
EV to EBITDA
45.12
EV to Capital Employed
3.41
EV to Sales
0.52
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-19.14%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Jun'25
Jun'25
Jun'24
Change(%)
Net Sales
377.20
370.10
1.92%
Operating Profit (PBDIT) excl Other Income
18.50
8.00
131.25%
Interest
13.70
17.90
-23.46%
Exceptional Items
-1.70
-58.10
97.07%
Consolidate Net Profit
-10.70
-65.70
83.71%
Operating Profit Margin (Excl OI)
14.20%
-9.10%
2.33%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2025 is 1.92% vs -52.16% in Jun 2024
Consolidated Net Profit
YoY Growth in year ended Jun 2025 is 83.71% vs -550.50% in Jun 2024
About Wai Chun Bio-Technology Ltd. 
Wai Chun Bio-Technology Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






